Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Google Hit with Antitrust Complaint by Danish Job Search Rival Jobindex f

https://jp.reuters.com/article/eu-alphabet-jobindex-antitrust/exclusive-google-hit-with-antitrust-complaint-by-danish-job-search-rival-idUSL8N2YB4MZ

byCharles Gross

June 27, 2022

1 minute read

https://jp.reuters.com/article/eu-alphabet-jobindex-antitrust/exclusive-google-hit-with-antitrust-complaint-by-danish-job-search-rival-idUSL8N2YB4MZ

Jefferies Maintains Buy on Snap, Lowers Price Target to $55

By Benzinga Newsdesk

Today, 11:55 AM

Jefferies analyst Brent Thill maintains Snap (NYSE:SNAP) with a Buy and lowers the price target from $65 to $55.

SNAP

Gilead Reports Submission Of Its Biologics License Application To FDA For Bulevirtide Treatment For People Living With Chronic Hepatitis Delta

By Benzinga Newsdesk

Today, 11:55 AM

-- If Approved, Bulevirtide Will Be the First Treatment Option for Adult Patients in the U. S. With Chronic Hepatitis Delta Virus Infection With Compensated Liver Disease -- FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead

GILD

Wolfe Research Downgrades SmileDirectClub to Peer Perform, Announces $7 Price Target

By Benzinga Newsdesk

Today, 11:55 AM

Wolfe Research analyst Steve Beuchaw downgrades SmileDirectClub (NASDAQ:SDC) from Outperform to Peer Perform and announces $7 price target.

SDC

U.S. Issues Fresh Russia-Related Sanctions

By Benzinga Newsdesk

Today, 11:55 AM

-Reuters

RSX

Google Hit with Antitrust Complaint by Danish Job Search Rival Jobindex f

Related Posts

Jefferies Maintains Buy on Snap, Lowers Price Target to $55

Gilead Reports Submission Of Its Biologics License Application To FDA For Bulevirtide Treatment For People Living With Chronic Hepatitis Delta

Wolfe Research Downgrades SmileDirectClub to Peer Perform, Announces $7 Price Target

U.S. Issues Fresh Russia-Related Sanctions